{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:52:06Z","timestamp":1793710326233,"version":"4.6.1"},"reference-count":47,"publisher":"Informa UK Limited","issue":"10","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2023,10,3]]},"DOI":"10.1080\/14740338.2023.2251380","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T02:40:18Z","timestamp":1692844818000},"page":"921-928","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":18,"title":["Ocular toxicities associated with antibody drug conjugates and immunotherapy in oncology: clinical presentation, pathogenesis, and management strategies"],"prefix":"10.1080","volume":"22","author":[{"given":"Farah","family":"Raheem","sequence":"first","affiliation":[{"name":"Clinical Pharmacy Specialist, Hematology\/Oncology, Assistant Professor of Pharmacy, Mayo Clinic College of Medicine and Science, Mayo Clinic Arizona, Phoenix, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Alsuhebany","sequence":"additional","affiliation":[{"name":"College of Pharmacy, oncology clinical pharmacist, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Hickey Zacholski","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Specialist, Gynecologic Oncology, VCU Health, Massey Cancer Center, Virginia Commonwealth University (VCU) School of Pharmacy, Richmond, VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikola","family":"Paulic","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Specialist, Oncology, Hospitals Geauga Medical Center, Willoughby, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sandler","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Uk","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Minnesota, Minneapolis, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald C.","family":"Moore","sequence":"additional","affiliation":[{"name":"Clinical Oncology Pharmacy Manager, Atrium Health Levine Cancer Institute, Charlotte, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,8,30]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-80898-7"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030713"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.701951"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/01676830.2020.1867192"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1177\/1758835921992989"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-00947-7"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-19-0582"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035807"},{"key":"e_1_3_5_10_1","unstructured":"PADCEV Prescribing Information [Internet]. Padcev_label. Astellas; [cited 2023 May 5]. Available from: https:\/\/astellas.us\/docs\/PADCEV_label.pdf"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01643"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-2275"},{"key":"e_1_3_5_13_1","unstructured":"Elahere Prescribing Information [Internet]. ELAHERE_PI. ImmunoGen; [cited 2023 May 5]. Available from: https:\/\/www.immunogen.com\/wp-content\/uploads\/2022\/11\/ELAHERE_PI.pdf"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01900"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000001805"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-2474"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2016.1156829"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2015.0064"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-3202"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nox202"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2007.01.002"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines4030014"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30736"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.69.9538"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00056-5"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2022.02.010"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11174993"},{"key":"e_1_3_5_28_1","unstructured":"Highlights of prescribing information tivdak \u2026 [Internet]. Tivdak_label. Seagen; [cited 2023 May 5]. Available from: https:\/\/docs.seagen.com\/Tivdak_Full_Ltr_Master.pdf"},{"key":"e_1_3_5_29_1","unstructured":"Center for Drug Evaluation and Research. Novel drug approvals for 2022 [Internet]. U.S. Food and Drug Administration. FDA; [cited 2023 May 5]. Available from: https:\/\/www.fda.gov\/drugs\/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products\/novel-drug-approvals-2022"},{"key":"e_1_3_5_30_1","unstructured":"Approval timelines of active immunotherapies [Internet]. Cancer Research Institute. Cancer Research Institute; 2023 [cited 2023 May 5]. Available from: https:\/\/stage.cancerresearch.org\/en-us\/scientists\/immuno-oncology-landscape\/fda-approval-timeline-of-active-immunotherapies"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2020.1773867"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.100958"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-002119"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2017.1296765"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.36401\/JIPO-22-14"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.18240\/ijo.2022.04.19"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joco.2019.05.002"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0000000000000239"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.108"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0000000000000394"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-022-01578-2"},{"key":"e_1_3_5_42_1","unstructured":"Common terminology criteria for adverse events (CTCAE) [Internet]. Common Terminology Criteria for adverse events (CTCAE). U.S. Department of health and human services; 2017 [cited 2023 May 5]. Available from: https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcae_v5_quick_reference_5x7.pdf"},{"key":"e_1_3_5_43_1","unstructured":"NCCN Guidelines Version 1. Management of immunotherapy-related toxicities. [Internet]. NCCN; 2022. [cited 2023 May 5]. Available from: https:\/\/www.nccn.org\/login?ReturnURL=https%3A%2F%2Fwww.nccn.org%2Fprofessionals%2Fphysician_gls%2Fpdf%2Fimmunotherapy.pdf"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.77.6385"},{"key":"e_1_3_5_45_1","unstructured":"Comprehensive adult eye and vision Examination [Internet]. American Optometric Association - EBO_Adult_Guildline_22. American Optometric Association; 2023 [cited 2023 May 5]. Available from: https:\/\/aoa.uberflip.com\/i\/1492068-ebo-adult-guildline-22\/0"},{"key":"e_1_3_5_46_1","unstructured":"Blenrep (belantamab mafodotin) injection [package insert]. NC: Research Park Triangle; 2020."},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000003162"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.678634"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2023.2251380","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T12:58:38Z","timestamp":1695301118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2023.2251380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,30]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10,3]]}},"alternative-id":["10.1080\/14740338.2023.2251380"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2023.2251380","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,30]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-05-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}